Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update

Go back to Evaxion Biotech Announces Second Quarter 2022 Financial Results and Provides Business Update

Evaxion Biotech (EVAX) Tops Q2 EPS by 10c

August 10, 2022 7:03 AM EDT

Evaxion Biotech (NASDAQ: EVAX) reported Q2 EPS of ($0.20), $0.10 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

... More